Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
13(38%)
Results Posted
44%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
10
29%
Ph early_phase_1
5
15%
Ph phase_1
3
9%
Ph phase_2
5
15%
Ph phase_4
2
6%

Phase Distribution

8

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
5(20.0%)
Phase 1Safety & dosage
3(12.0%)
Phase 2Efficacy & side effects
5(20.0%)
Phase 4Post-market surveillance
2(8.0%)
N/ANon-phased studies
10(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

13

trials recruiting

Total Trials

34

all time

Status Distribution
Active(15)
Completed(9)
Terminated(3)
Other(7)

Detailed Status

Recruiting12
Completed9
unknown7
Withdrawn2
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
13
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (20.0%)
Phase 13 (12.0%)
Phase 25 (20.0%)
Phase 42 (8.0%)
N/A10 (40.0%)

Trials by Status

active_not_recruiting13%
completed926%
recruiting1235%
terminated13%
unknown721%
withdrawn26%
not_yet_recruiting26%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT05627908

The PseAn Study - Study Protocol

Recruiting
NCT07436364Early Phase 1

Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Recruiting
NCT06146764

CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Recruiting
NCT06639828Phase 4

Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging

Recruiting
NCT04715958Phase 2

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

Recruiting
NCT05641935Phase 2

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

Recruiting
NCT06261814Phase 2

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Recruiting
NCT06171607Phase 1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Recruiting
NCT03490929Phase 4

CEUS for Blunt Abdominal Trauma in Children

Recruiting
NCT07272083

New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules

Not Yet Recruiting
NCT04821284Phase 1

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Active Not Recruiting
NCT05328167Phase 2

Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

Completed
NCT05105087Early Phase 1

Gynecological Sentinel Lymph Nodes CEUS

Completed
NCT03578224Early Phase 1

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Completed
NCT06460142

Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic

Recruiting
NCT06727162

The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC

Recruiting
NCT06590948

Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS

Recruiting
NCT01566890Not Applicable

Microvascular Blood Flow in Sickle Cell Anemia

Completed
NCT06353659

The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Not Yet Recruiting
NCT04614389Not Applicable

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

Terminated

Drug Details

Intervention Type
OTHER
Total Trials
34